Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CASI Pharmaceuticals (CASI) Inventory (2021 - 2025)

Historic Inventory for Pharmaceuticals (CASI) over the last 5 years, with Q2 2025 value amounting to $3.4 million.

  • Pharmaceuticals' Inventory fell 9997.68% to $3.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.4 million, marking a year-over-year decrease of 9997.68%. This contributed to the annual value of $5.3 million for FY2024, which is 9996.69% down from last year.
  • As of Q2 2025, Pharmaceuticals' Inventory stood at $3.4 million, which was down 9997.68% from $4.2 billion recorded in Q1 2025.
  • Pharmaceuticals' 5-year Inventory high stood at $15.9 billion for Q4 2023, and its period low was $1.9 million during Q4 2021.
  • Moreover, its 5-year median value for Inventory was $15.4 million (2024), whereas its average is $4.7 billion.
  • As far as peak fluctuations go, Pharmaceuticals' Inventory skyrocketed by 25856731.83% in 2023, and later crashed by 9997.68% in 2025.
  • Over the past 5 years, Pharmaceuticals' Inventory (Quarter) stood at $1.9 million in 2021, then skyrocketed by 221.87% to $6.1 million in 2022, then soared by 258567.32% to $15.9 billion in 2023, then plummeted by 99.97% to $5.3 million in 2024, then crashed by 35.32% to $3.4 million in 2025.
  • Its Inventory stands at $3.4 million for Q2 2025, versus $4.2 billion for Q1 2025 and $5.3 million for Q4 2024.